Decreased platelet miR-223 expression is associated with high on-clopidogrel platelet reactivity - Shi, Rui; Ge, Lan; Zhou, Xin; Ji, Wen-Jie; Lu, Rui-Yi; Zhang, Ying-Ying; Zeng, Shan; Liu, Xing; Zhao, Ji-Hong; Zhang, Wen-Cheng; Jiang, Tie-Min; Li, Yu-Ming (Thrombosis research, 2013)
Keywords: Aged; Blood Platelets - drug effects; Blood Platelets - metabolism; Clopidogrel; Coronary Disease - drug therapy; Coronary Disease - genetics; Down-Regulation - drug effects; Female; Hematology, Oncology and Palliative Medicine; High on-treatment platelet reactivity; Humans; Male; MicroRNAs - genetics; Middle Aged; MiroRNAs; Platelet Aggregation - drug effects; Platelet Aggregation Inhibitors - pharmacology; Platelet Aggregation Inhibitors - therapeutic use; Platelet function test; Platelet Function Tests; Ticlopidine - analogs & derivatives; Ticlopidine - pharmacology; Ticlopidine - therapeutic use; Vasodilator-stimulated phosphoprotein; miRNAs; PRI; LVEF; PPI; cGMP; cAMP; UA; ADP; Cr; MFI; RBC; DBP; ACEI; real time PCR; WBC; BMI; SBP; VASP; CCB; NSTE-ACS; PGE1; Ago; 3’UTR; Platelet function test; TB; Vasodilator-stimulated phosphoprotein; TC; ARB; TG; High on-treatment platelet reactivity; MiroRNAs; PAG; PCI; LDPs; Clopidogrel; CHD; microRNAs; red blood cells; vasodilator-stimulated phosphoprotein; systolic blood pressure; total cholesterol; left ventricular ejection fraction; percutaneous coronary intervention; diastolic blood pressure; prostaglandin E1; white blood cells; adenosine diphosphate; uric acid; argonaute; mean fluorescence intensity; body mass index; angiotensin-converting enzyme inhibitor; 3’untranslated region; cyclic guanosine monophosphate; total bilirubin; leukocyte-depleted platelets; platelet aggregation; proton pump inhibitors; platelet reactivity index; creatinine; angiotensin receptor blockers; calcium channel blockers; triglycerides; cyclic adenosine monophosphate; real time polymerase chain reaction; coronary heart disease; non-ST-segment elevation acute coronary syndrome